Health Subcommittee, Energy and Commerce Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Humane Cosmetics Act of 2021 This bill generally prohibits animal testing in the evaluation of cosmetic products, and it prohibits the sale or transport of cosmetics developed using animal testing, subject to civil penalties. These prohibitions begin one year after enactment. The bill specifies exceptions to these prohibitions, including if such animal testing (1) is conducted outside the United States to comply with a foreign regulatory authority; (2) is pursuant to a specified finding that there are no nonanimal alternatives to test the safety of a potentially dangerous cosmetic product or ingredient; (3) is of a product or ingredient for a drug or device subject to regulation by the Food and Drug Administration (FDA); or (4) is required for a noncosmetic purpose pursuant to a state, federal, or foreign regulatory authority. Further, no animal-testing evidence may be used to establish the safety of a cosmetic product or ingredient that is regulated by the FDA after the effective date of this bill, subject to limited exceptions.
Animal protection and human-animal relationshipsBusiness recordsCivil actions and liabilityCongressional oversightConsumer affairsCosmetics and personal careDrug safety, medical device, and laboratory regulationFederal preemptionGovernment information and archivesMarketing and advertisingProduct development and innovationProduct safety and qualityResearch administration and fundingRetail and wholesale tradesState and local government operations
Humane Cosmetics Act of 2021
USA117th CongressHR-6207| House
| Updated: 12/10/2021
Humane Cosmetics Act of 2021 This bill generally prohibits animal testing in the evaluation of cosmetic products, and it prohibits the sale or transport of cosmetics developed using animal testing, subject to civil penalties. These prohibitions begin one year after enactment. The bill specifies exceptions to these prohibitions, including if such animal testing (1) is conducted outside the United States to comply with a foreign regulatory authority; (2) is pursuant to a specified finding that there are no nonanimal alternatives to test the safety of a potentially dangerous cosmetic product or ingredient; (3) is of a product or ingredient for a drug or device subject to regulation by the Food and Drug Administration (FDA); or (4) is required for a noncosmetic purpose pursuant to a state, federal, or foreign regulatory authority. Further, no animal-testing evidence may be used to establish the safety of a cosmetic product or ingredient that is regulated by the FDA after the effective date of this bill, subject to limited exceptions.
Animal protection and human-animal relationshipsBusiness recordsCivil actions and liabilityCongressional oversightConsumer affairsCosmetics and personal careDrug safety, medical device, and laboratory regulationFederal preemptionGovernment information and archivesMarketing and advertisingProduct development and innovationProduct safety and qualityResearch administration and fundingRetail and wholesale tradesState and local government operations